Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 638

    1.

    The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.

    Sheard L, Wright NM, El-Sayeh HG, Adams CE, Li R, Tompkins CN.

    Subst Abuse Treat Prev Policy. 2009 Feb 5;4:1.

    PMID:
    19196468
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.

    Wright NM, Sheard L, Tompkins CN, Adams CE, Allgar VL, Oldham NS.

    BMC Fam Pract. 2007 Jan 8;8:3.

    PMID:
    17210079
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.

    Wright NM, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, Hart R, Tompkins CN.

    Br J Gen Pract. 2011 Dec;61(593):e772-80.

    PMID:
    22137413
    [PubMed - in process]
    7.

    Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.

    Robertson JR, Raab GM, Bruce M, McKenzie JS, Storkey HR, Salter A.

    Addiction. 2006 Dec;101(12):1752-9.

    PMID:
    17156174
    [PubMed - indexed for MEDLINE]
    8.

    A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.

    Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N.

    Med J Aust. 2003 Jul 7;179(1):38-42.

    PMID:
    12831383
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.

    Raistrick D, West D, Finnegan O, Thistlethwaite G, Brearley R, Banbery J.

    Addiction. 2005 Dec;100(12):1860-7.

    PMID:
    16367987
    [PubMed - indexed for MEDLINE]
    10.

    Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

    Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D; Buprenorphine/Naloxone Collaborative Study Group.

    N Engl J Med. 2003 Sep 4;349(10):949-58.

    PMID:
    12954743
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review.

    Horspool MJ, Seivewright N, Armitage CJ, Mathers N.

    Eur Addict Res. 2008;14(4):179-85. Epub 2008 Jun 27. Review.

    PMID:
    18583914
    [PubMed - indexed for MEDLINE]
    13.

    The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.

    Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M.

    Br J Gen Pract. 2005 Jun;55(515):444-51.

    PMID:
    15970068
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Random mandatory drugs testing of prisoners: a biassed means of gathering information.

    Gore SM, Bird AG, Strang JS.

    J Epidemiol Biostat. 1999;4(1):3-9.

    PMID:
    10613711
    [PubMed - indexed for MEDLINE]
    15.

    Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.

    Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.

    Am J Psychiatry. 2005 Feb;162(2):340-9.

    PMID:
    15677600
    [PubMed - indexed for MEDLINE]
    16.

    Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

    Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

    Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

    PMID:
    16203961
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.

    White R, Alcorn R, Feinmann C.

    Drug Alcohol Depend. 2001 Dec 1;65(1):77-83.

    PMID:
    11714592
    [PubMed - indexed for MEDLINE]
    18.

    Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users.

    Gandhi DH, Jaffe JH, McNary S, Kavanagh GJ, Hayes M, Currens M.

    Addiction. 2003 Apr;98(4):453-62.

    PMID:
    12653815
    [PubMed - indexed for MEDLINE]
    19.

    Substance use in remand prisoners: a consecutive case study.

    Mason D, Birmingham L, Grubin D.

    BMJ. 1997 Jul 5;315(7099):18-21.

    PMID:
    9233320
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.

    Gross A, Marsch LA, Badger GJ, Bickel WK.

    Exp Clin Psychopharmacol. 2006 May;14(2):148-56.

    PMID:
    16756418
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk